Preclinical News and Research

RSS
S*BIO initiates trials of oral JAK2 inhibitor for hematological malignancies

S*BIO initiates trials of oral JAK2 inhibitor for hematological malignancies

Discovery of promising new chemotherapy target for a deadly form of leukemia

Discovery of promising new chemotherapy target for a deadly form of leukemia

Geron issued U.S. patent for cardiomyocytes from human embryonic stem cells

Geron issued U.S. patent for cardiomyocytes from human embryonic stem cells

Novel treatment for prostate cancer

Novel treatment for prostate cancer

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Domainex has core intellectual property rights granted for Europe

Domainex has core intellectual property rights granted for Europe

Naltrexone-derived pyridomorphinan shows promise for treatment of alcoholism

Naltrexone-derived pyridomorphinan shows promise for treatment of alcoholism

Domainex, has core intellectual property rights granted for Europe

Domainex, has core intellectual property rights granted for Europe

Eastern Virginia Medical School receives $100 million grant from USAID for microbicide research

Eastern Virginia Medical School receives $100 million grant from USAID for microbicide research

Coated lenses set to reduce 'post-op' infections for cataract patients

Coated lenses set to reduce 'post-op' infections for cataract patients

Panacea Pharmaceuticals issued U.S. patent for anti-HAAH antibodies

Panacea Pharmaceuticals issued U.S. patent for anti-HAAH antibodies

Vimpat (lacosamide) approved in Europe

Vimpat (lacosamide) approved in Europe

FDA authorizes INDA for recombinant human C1 inhibitor in kidney transplantation

FDA authorizes INDA for recombinant human C1 inhibitor in kidney transplantation

Nature inspires new highly specific drugs and organic products

Nature inspires new highly specific drugs and organic products

MorphoSys announces publication of first MOR103 data

MorphoSys announces publication of first MOR103 data

New molecular imaging techniques aim at detection of earliest steps of disease development

New molecular imaging techniques aim at detection of earliest steps of disease development

FDA grants IND for Davanat to treat breast cancer patient

FDA grants IND for Davanat to treat breast cancer patient

Genzyme, Medicines for Malaria Venture, Advinus collaborate on malaria initiative

Genzyme, Medicines for Malaria Venture, Advinus collaborate on malaria initiative

VioQuest Pharmaceuticals issued new U.S. patent for Lenocta

VioQuest Pharmaceuticals issued new U.S. patent for Lenocta

Galapagos acquires structure-based drug discovery from Sareum

Galapagos acquires structure-based drug discovery from Sareum

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.